Description
The COST Action SNOOPY will bring together a network of experts and young researchers from diverse disciplines (chemistry, biology, biochemistry, materials science, nanotechnology, medicine, physics) to overcome existing barriers to predict and implement bioactive peptides’ ability to self-assemble into functional nanostructures, including those at the interface with membranes, potentially forming pores and channels. This is a fast-growing field with enormous potential for therapy (including targeted cancer therapy, drug delivery, amyloidosis inhibition, regenerative medicine, membrane channels, and antimicrobials), and for the development of nanotechnological tools that could include potential use in diagnostics, optics, catalysis, and bioelectronics. Theoreticians and experimentalists of the SNOOPY Action will synergize to enable in silico predictions of self-assembly behavior, as well as to develop new advanced characterization methods, and to produce them and test them too. The expertise gathered by the Action will be applied to train and build the career of younger members. The geopolitical balance of the Action is strategically set to level the gap between COST Members, and to make of its diversity a tactical asset to boost creativity and foster new ideas. The Action will have socioeconomical impact through the search for new diagnostic and therapeutic solutions to address some of the most formidable challenges of the society (e.g., advance our understanding of amyloidoses and antimicrobial resistance), to assist scientists and industry in the development of new technologies (e.g., peptide nanostructures as vaccine adjuvants) and to develop more sustainable processes (e.g., greener peptide synthesis, or using peptides as biodegradable substitutes to polluting alternatives).
Action keywords
peptides - nanostructures - antimicrobial - amyloids - self-assembly
Management Committee
Country | MC Member |
---|---|
Austria | |
Austria | |
Belgium | |
Bosnia and Herzegovina | |
Bulgaria | |
Croatia | |
Cyprus | |
Cyprus | |
Czech Republic | |
Denmark | |
Estonia | |
Estonia | |
Finland | |
Germany | |
Germany | |
Greece | |
Greece | |
Ireland | |
Israel | |
Israel | |
Italy | |
Italy | |
Latvia | |
Latvia | |
Lithuania | |
North Macedonia | |
North Macedonia | |
Norway | |
Norway | |
Poland | |
Poland | |
Portugal | |
Portugal | |
Romania | |
Romania | |
Serbia | |
Serbia | |
Spain | |
Spain | |
Sweden | |
Switzerland | |
Türkiye | |
United Kingdom | |
United Kingdom |
Main Contacts
Action Contacts
COST Staff
Leadership
Role | Leader |
---|---|
Action Chair | |
Action Vice-Chair | |
Grant Holder Scientific Representative | |
Science Communication Coordinator | |
Grant Awarding Coordinator | |
WG1 Leader | |
WG2 Leader | |
WG3 Leader | |
WG4 Leader |
Additional roles
Role | Leader |
---|---|
STSM Coordinator | |
Training & Development Coordinator | |
WG1 co-leader | |
WG2 co-leader | |
WG3 co-leader | |
WG4 co-leader |
Working Groups
Number | Title | Leader |
---|---|---|
1 | Computational methods for assessment of peptides & peptide nanostructures | |
2 | Production and characterization of bioactive peptides & peptide nanostructures | |
3 | Biological study and applications of peptides & related nanostructures | |
4 | Communication & Dissemination |
Express your interest to join any of the working groups by applying below.
It is required to have an e-COST profile to submit your application. If needed, create it first and then click 'Apply'.
ApplyMembership
Name | Working Group | Country |
---|---|---|
WG 1, WG 2, WG 3, WG 4 | Spain | |
WG 1, WG 4 | Croatia | |
WG 1, WG 4 | Portugal | |
WG 1, WG 3 | Italy | |
WG 1, WG 3 | Croatia | |
WG 1, WG 2 | Serbia | |
WG 1 | Croatia | |
WG 1 | Netherlands | |
WG 1, WG 4 | Serbia | |
WG 1, WG 3 | Netherlands | |
WG 1 | Portugal | |
WG 1, WG 3 | Romania | |
WG 1, WG 4 | Spain | |
WG 1 | Portugal | |
WG 1 | Portugal | |
WG 1 | Croatia | |
WG 1 | Croatia | |
WG 1, WG 4 | Serbia | |
WG 1, WG 3 | Czechia | |
WG 1, WG 3 | Italy | |
WG 1, WG 2 | United Kingdom | |
WG 2, WG 3, WG 4 | Germany | |
WG 2, WG 3 | Portugal | |
WG 2, WG 3 | Spain | |
WG 2 | United Kingdom | |
WG 2, WG 3 | Cyprus | |
WG 2, WG 4 | Spain | |
WG 2, WG 3 | Portugal | |
WG 2, WG 3 | Austria | |
WG 2, WG 3 | Greece | |
WG 2, WG 3 | Portugal | |
WG 2 | Croatia | |
WG 2 | Italy | |
WG 2, WG 3 | Italy | |
WG 2, WG 3 | Spain | |
WG 2 | Romania | |
WG 2, WG 3, WG 4 | United Kingdom | |
WG 2, WG 4 | Spain | |
WG 2, WG 3 | Spain | |
WG 2 | Sweden | |
WG 2 | Italy | |
WG 2 | United Kingdom | |
WG 2, WG 3 | Denmark | |
WG 2, WG 3 | Portugal | |
WG 2, WG 3 | Switzerland | |
WG 2, WG 3, WG 4 | Estonia | |
WG 2, WG 3 | United Kingdom | |
WG 2, WG 3 | Israel | |
WG 2 | Croatia | |
WG 2, WG 4 | Romania | |
WG 2, WG 3, WG 4 | Norway | |
WG 2, WG 3 | Italy | |
WG 2, WG 3 | Czechia | |
WG 2, WG 3 | Israel | |
WG 2 | Spain | |
WG 2, WG 3, WG 4 | Türkiye | |
WG 2 | Croatia | |
WG 2, WG 3 | Israel | |
WG 2, WG 3 | Finland | |
WG 2 | Italy | |
WG 2, WG 4 | Croatia | |
WG 2, WG 4 | Poland | |
WG 2, WG 3, WG 4 | Austria | |
WG 2 | Croatia | |
WG 2 | Italy | |
WG 2, WG 3 | Italy | |
WG 2, WG 4 | United Kingdom | |
WG 2 | Slovenia | |
WG 2, WG 4 | Croatia | |
WG 2 | Ireland | |
WG 2 | Italy | |
WG 2, WG 3 | Lithuania | |
WG 2, WG 3, WG 4 | Portugal | |
WG 2, WG 3 | Portugal | |
WG 2, WG 3 | Portugal | |
WG 3 | Belgium | |
WG 3, WG 4 | Serbia | |
WG 3 | Estonia | |
WG 3, WG 4 | North Macedonia | |
WG 3, WG 4 | Poland | |
WG 3 | Austria | |
WG 3 | Latvia | |
WG 3, WG 4 | Croatia | |
WG 3, WG 4 | Serbia | |
WG 3 | Croatia | |
WG 3, WG 4 | Portugal | |
WG 3 | Lithuania | |
WG 3 | Bosnia & Herzegovina | |
WG 3, WG 4 | Finland | |
WG 4 | North Macedonia |